Weaver Consulting Group Dexcom Inc Transaction History

Weaver Consulting Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$78.0 - $104.5 $3,120 - $4,180	-40 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$95.51 - $112.95 $3,820 - $4,518	40 New	40 $17,000
Q2 2020 Jul 24, 2020	SELL	$62.68 - $105.34 $6,330 - $10,639	-101 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$47.79 - $75.63 $4,826 - $7,638	101 New	101 $27,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

Stay updated on Weaver Consulting Group with notifications on news.